Over 18000 lives are lost to cancer every year according to the global cancer statistics. Breast and prostate cancers are the ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

A new BD will have four new operating segments: medical essentials, connected care, BioPharma systems and interventional.

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

The FDA is getting the word out on a high-risk issue related to artery-clearing catheters from BD’s Bard Peripheral Vascular ...

The BD FACSVerse™ flow cytometer was engineered from the ground up to offer remarkable performance, flexibility, and ease of operation for research applications using up to 10 parameters.

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

Presents Shares and Growth Trends for Flow Cytometry, Hematology Analysers, Cell Imaging Systems, Reagents & Kits, and Other ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The global Tissue Engineering Market , valued at US$4.3 billion in 2022, is forecasted to grow at a robust CAGR of 15.3%, ...